IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,390 | +11.5% | 67 | 0.0% | 0.00% | – |
| Q3 2023 | $3,039 | +17.6% | 67 | +6.3% | 0.00% | – |
| Q2 2023 | $2,585 | +100.9% | 63 | +75.0% | 0.00% | – |
| Q1 2023 | $1,287 | +128600.0% | 36 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 36 | -12.2% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 41 | -31.7% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 60 | +25.0% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 48 | +118.2% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 22 | -65.6% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 64 | +93.9% | 0.00% | – |
| Q1 2021 | $1,000 | -100.0% | 33 | -66.0% | 0.00% | -100.0% |
| Q4 2016 | $4,640,000 | +105.4% | 97 | 0.0% | 0.00% | – |
| Q2 2016 | $2,259,000 | -42.5% | 97 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $3,928,000 | -34.6% | 97 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $6,007,000 | – | 97 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |